- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Parkinson's disease drugs and pharmacogenetic considerations
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 9, Issue 7, Pages 859-874
Publisher
Informa Healthcare
Online
2013-04-09
DOI
10.1517/17425255.2013.789018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem
- (2013) Kathrin Klein et al. Frontiers in Genetics
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
- (2013) Ulrich M. Zanger et al. Frontiers in Genetics
- Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease
- (2012) Lissa S. Brod et al. MOVEMENT DISORDERS
- DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients
- (2012) Mariana Rieck et al. PHARMACOGENOMICS
- The Differential Effect of NAT2 Variant Alleles Permits Refinement in Phenotype Inference and Identifies a Very Slow Acetylation Genotype
- (2012) Jhon D. Ruiz et al. PLoS One
- Trends in Qualifying Biomarkers in Drug Safety. Consensus of the 2011 Meeting of the Spanish Society of Clinical Pharmacology
- (2012) José A. G. Agúndez et al. Frontiers in Pharmacology
- Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function
- (2011) Willi Cawello et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacological treatment and the prospect of pharmacogenetics in Parkinson’s disease
- (2011) K. Kalinderi et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Development and validation of a high-performance liquid chromatography-electrospray ionization-MS/MS method for the simultaneous quantitation of levodopa and carbidopa in human plasma
- (2011) Isabela Costa César et al. JOURNAL OF MASS SPECTROMETRY
- Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium
- (2011) V. McGuire et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population
- (2011) Juan Gonzalo Restrepo et al. Pharmacogenetics and Genomics
- Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers
- (2011) Lutz P Breitling et al. PHARMACOGENOMICS
- The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial
- (2010) Jean-Christophe Corvol et al. ANNALS OF NEUROLOGY
- Pharmacogenomics in Drug Induced Liver Injury
- (2010) Raul Andrade et al. CURRENT DRUG METABOLISM
- Phenomics: the next challenge
- (2010) David Houle et al. NATURE REVIEWS GENETICS
- Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
- Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
- (2009) Maurits E. L. Arbouw et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson’s disease patients
- (2009) Ying-Zi Liu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
- (2009) José AG Agúndez et al. Expert Opinion on Drug Metabolism & Toxicology
- Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor
- (2009) Elena García-Martín et al. MOVEMENT DISORDERS
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
- (2008) Ulrich M. Zanger et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Unraveling Ambiguous NAT2 Genotyping Data
- (2008) J. A. G. Agundez et al. CLINICAL CHEMISTRY
- Interethnic and Intraethnic Variability of NAT2 Single Nucleotide Polymorphisms
- (2008) Elena Garcia-Martin CURRENT DRUG METABOLISM
- The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinsonʼs disease, levodopa treatment response, and complications
- (2008) Monika Bialecka et al. Pharmacogenetics and Genomics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More